Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Dalantercept |
Trade Name | |
Synonyms | ACE-041|ALK1-Fc |
Drug Descriptions |
Dalantercept (ACE-041) is an ALK1 ligand trap composed of the ALK1 extracellular domain linked to the IgG Fc region, which binds to ALK1 ligands and prevents binding to the receptor, potentially leading to decreased tumor angiogenesis and growth and increased sensitivity to chemotherapeutic agents (PMID: 25708802, PMID: 26373572, PMID: 20124460, PMID: 30951193). |
DrugClasses | ALK Inhibitor 32 |
CAS Registry Number | 1186210-24-1 |
NCIT ID | C88296 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Axitinib + Dalantercept | Axitinib Dalantercept | 0 | 1 |
Cisplatin + Dalantercept | Cisplatin Dalantercept | 2 | 0 |
Dalantercept | Dalantercept | 1 | 0 |
Dalantercept + Doxorubicin | Dalantercept Doxorubicin | 1 | 0 |
Dalantercept + Sorafenib | Dalantercept Sorafenib | 0 | 1 |